Scabies Treatment Guide

Most patients who come to us with scabies have been itching for weeks — sometimes months — before they get the right diagnosis. In my experience, scabies is one of the most commonly misidentified skin conditions in primary care. It gets labeled as eczema, contact dermatitis, or a stress rash, and the patient keeps scratching while the mites keep spreading.

The good news: scabies is entirely curable. The frustrating reality: it requires precise treatment technique, simultaneous treatment of everyone in the household, and patience through several weeks of post-treatment itch that many patients mistake for treatment failure.

This guide covers everything you need to know — the biology of the mite, how to distinguish scabies from look-alike conditions, exactly how first-line medications work and how to use them correctly, the management of crusted scabies in immunocompromised patients, and what to do when the itch persists after the mites are gone.

What Is Scabies? Understanding the Mite

Scabies is an infestation of the skin caused by Sarcoptes scabiei var. hominis — the human itch mite.^[1] This eight-legged parasite is about 0.3–0.4 mm long, invisible to the naked eye, and spends its entire life cycle in or on human skin. It cannot survive on animals, so your pets do not need treatment and cannot transmit the mite back to you.

A fertilized female mite burrows into the outermost layer of skin (the stratum corneum) and tunnels along the surface, depositing eggs and fecal pellets (called scybala) as she goes. A single female lays 2–3 eggs per day over her 1–2 month lifespan. In a typical case of classic scabies, you are hosting approximately 10–15 mites at any given time — an infestation that is surprisingly small but still capable of causing relentless, body-wide itch.

The intense itching is not caused directly by the mites burrowing. It is your immune system responding — with increasing intensity over time — to mite proteins, eggs, and fecal matter in the skin.^[2] This explains two clinically important facts: first, a person exposed to scabies for the first time may not itch for 4 to 8 weeks (before the immune response fully develops); second, even after successful treatment, the itch can persist for weeks as the immune system continues reacting to residual dead mite material.

Where Burrows Appear

Burrows are the pathognomonic sign of scabies — thin, grayish-white or skin-colored zigzag lines, 2–10 mm long, often with a small dot (the mite) at one end. They appear most reliably in areas where the skin is thin and warm:

• Webbing between the fingers and toes
• Inner wrists and forearms
• Armpits and around the beltline
• Genitals (especially in men — genital involvement is a strong clue for scabies)
• Nipples and areolae in women
• Buttocks and buttocks crease
• Shoulder blades

In infants and young children, burrows also appear on the scalp, face, neck, palms, and soles of the feet — areas that are typically spared in adults.^[1] Elderly patients and immunocompromised individuals may have atypical presentations with more widespread or crusted lesions.

How Scabies Spreads

The primary route of transmission is prolonged, direct skin-to-skin contact. A brief handshake is unlikely to transmit scabies; holding hands for an extended period, sharing a bed, or sexual contact provides sufficient time for mites to transfer from one person to another. The scabies mite moves slowly (2.5 cm per minute on warm skin) and cannot jump or fly.

The mite can survive off a human host for 2–3 days under normal conditions, which means sharing clothing, towels, or bedding with an infested person carries some risk — though this is a secondary route compared to direct contact.^[1] Scabies spreads readily in crowded settings: nursing homes, prisons, military barracks, childcare centers, and households with multiple occupants.

Diagnosis: Scabies vs. Eczema vs. Contact Dermatitis

Scabies is one of the great mimics in dermatology. I have seen it misdiagnosed repeatedly as atopic dermatitis, nummular eczema, contact dermatitis, drug reactions, and even autoimmune conditions. Weeks of treatment with steroid cream for presumed eczema — while the mites continue burrowing — is a common scenario by the time the correct diagnosis is made.

Confirming the Diagnosis

A definitive diagnosis requires finding the mite, eggs, or scybala (fecal pellets) on microscopic examination of a skin scraping taken from a burrow. The test is painless — a blade gently scrapes the skin surface, and the material is placed on a glass slide with mineral oil for microscopy. A negative scraping does not rule out scabies; with only 10–15 mites present, finding one depends heavily on sampling the right location.^[1]

Dermoscopy (a magnified skin surface examination) has become a useful clinical tool. The "jet with contrail" sign — a dark triangular structure (the mite's front end) at the end of a whitish, curvilinear burrow — is a reliable dermoscopic marker that can be identified without a formal scraping.

In clinical practice, many diagnoses are made on strong clinical grounds alone — characteristic burrows in classic locations, simultaneous household cases, and failure of eczema treatments — and empiric scabicide treatment is initiated without waiting for microscopic confirmation.

Treatment: First-Line Medications

All scabies treatment requires a prescription. Over-the-counter products are not effective and have not been approved for scabies.^[2] Two medications dominate first-line treatment: permethrin 5% cream (topical) and oral ivermectin (systemic). Both are effective; the choice between them depends on patient age, weight, pregnancy status, and extent of disease.

Permethrin 5% Cream: First-Line Topical Treatment

Permethrin 5% cream is FDA-approved for scabies in patients 2 months of age and older, including pregnant women.^[3] It is a synthetic pyrethroid that disrupts the nervous system of the mite, causing paralysis and death. Less than 2% of the applied dose is absorbed through intact skin, making systemic toxicity minimal.

Application errors are the leading cause of treatment failure — not drug resistance.^[5] In my clinical experience, patients who report that permethrin "didn't work" almost always missed the hands, skipped the feet, or applied to damp skin that diluted the medication. Treating the cream like sunscreen — applied liberally to every surface, with attention to the small details — makes all the difference.

Oral Ivermectin: Systemic Treatment

Oral ivermectin is not FDA-approved specifically for scabies, but it is widely used off-label and has efficacy comparable to permethrin 5% cream in clinical studies.^[2] For classic scabies, the standard dosing is 200 mcg per kilogram of body weight, taken with food (a meal increases bioavailability), with a second dose 7–14 days later. The two-dose schedule is necessary because ivermectin, like permethrin, has limited ovicidal activity — the second dose kills mites that hatched after the first treatment.^[4]

Ivermectin is not established as safe in children weighing less than 15 kg or in pregnant women, and it is classified as Category C in pregnancy. Permethrin 5% cream is the preferred option for these populations. Ivermectin has a strong safety record in adults and older children and is particularly useful when compliance with full-body topical application is a concern, for patients with mobility limitations, or in institutional outbreak scenarios where oral treatment is more practical to administer to large groups.

Comparing First-Line Options

Crusted (Norwegian) Scabies in Immunocompromised Patients

Crusted scabies is a different condition from classic scabies in almost every clinically relevant way — in severity, mite burden, contagiousness, and treatment requirements. While a typical scabies patient hosts 10–15 mites, a patient with crusted scabies may harbor millions of mites within thick, hyperkeratotic (crusty) skin plaques.

The condition develops when the immune system cannot mount an effective response to the infestation, allowing the mite population to grow unchecked. Risk groups include:^[2]

• HIV/AIDS patients, particularly with low CD4 counts
• Organ transplant recipients on immunosuppressive regimens
• Patients receiving chemotherapy or long-term systemic corticosteroids
• Elderly individuals with dementia in long-term care facilities
• Patients with lymphoma, leukemia, or other hematologic malignancies
• Individuals with HTLV-1 infection

Clinical Presentation

The rash in crusted scabies is distinctive: thick, gray-white or yellowish crusts form predominantly on the hands, feet, scalp, and under the nails. The crusts can involve large body surface areas and are friable — they break apart easily, releasing thousands of mites that can survive for days in the environment. Paradoxically, some patients with crusted scabies have relatively mild itch despite the massive mite burden, because the immune suppression that allows the infestation to grow also blunts the allergic itch response.

Crusted scabies is extraordinarily contagious. A single undiagnosed patient in a nursing home can trigger a facility-wide outbreak involving dozens of residents and staff through relatively brief contact — or even through environmental fomites from shed skin crusts.

Treatment Protocol for Crusted Scabies

Topical therapy alone is insufficient. The thick crusts prevent permethrin from penetrating to the mites living deep within them, and the sheer number of mites overwhelms a single topical application. First-line treatment requires both oral ivermectin and permethrin 5% cream, used together.^[2]

Treating Contacts and Decontaminating Your Home

Treating only the diagnosed patient while leaving household contacts and the home environment untreated is the most reliable way to fail. Reinfestation from an untreated partner or family member is the single most common cause of apparent "treatment failure" — and it has nothing to do with the medication itself.

Simultaneous Contact Treatment

The CDC and the American Academy of Dermatology both recommend that all household members and close contacts — including sexual partners from the prior 2 months — be treated on the same day as the patient, regardless of whether they have symptoms.^[3] A person exposed to scabies for the first time may carry mites for 4–8 weeks before developing any itch or rash. During that entire period, they can silently reinfest treated household members.

What I tell patients in practice: treat everyone in the house on the same night. Set all the permethrin cream out on the same counter, with everyone's name on it. Do it together. Coordinating treatment as a household — rather than treating one person at a time as they become symptomatic — is what breaks the cycle.

Fomite Decontamination: What to Wash and What Not to Panic About

The scabies mite cannot survive off a human host for more than 2–3 days under normal conditions. This puts the decontamination task in perspective — you are not dealing with an organism that can live for weeks in your carpet or furniture. Still, washing recently used items on the day treatment begins is an important precaution.

• Machine wash on the day you start treatment: All clothing worn in the past 3 days, bed linens, pillowcases, blankets, towels, and washcloths. Use the hottest water setting available. Dry on high heat (temperatures above 122°F / 50°C for 10 minutes kill mites and eggs).^[4]
• Items that cannot be washed: Seal in a plastic bag for at least 72 hours to one week. Mites will die without a human host. This applies to stuffed animals, certain clothing, or items the patient used recently.
• Vacuum carpets and upholstered furniture on the day treatment starts. Dispose of the vacuum bag immediately after.
• Do not use pesticide sprays or fumigants on furniture or in your home. They are unnecessary, potentially toxic, and not recommended by the CDC.^[2]
• Pets do not need treatment. Sarcoptes scabiei var. hominis cannot complete its life cycle on animals. Your dog's mange is caused by a different mite species.

The Itch After Treatment: What to Expect

Here is what I tell every patient before they leave with their prescription: the itch will almost certainly continue after treatment, and that is expected. Post-scabies pruritus is one of the most common reasons patients call back or come back in after treating scabies — and it is routinely misinterpreted as treatment failure.

After permethrin or ivermectin kills the mites, dead mite bodies, eggs, and fecal material remain in the skin. Your immune system — now fully sensitized from weeks or months of exposure — continues reacting to these residual antigens. The itch is your body's delayed hypersensitivity response, not evidence that any live mites remain.^[6]

Managing Post-Scabies Pruritus

Symptom management during the post-treatment period focuses on calming the inflammatory response:

• Topical corticosteroids (mid-potency, such as triamcinolone 0.1% cream) applied to itchy areas reduce inflammation and provide meaningful relief. This is the most used management approach.
• Oral antihistamines — particularly sedating agents like diphenhydramine (Benadryl) or hydroxyzine taken at night — help control itch and improve sleep during the recovery period.
• Fragrance-free moisturizers help restore the skin barrier and reduce irritant-driven itch.
• Pramoxine lotion (OTC topical anesthetic) provides localized itch relief without steroids.
• For severe or prolonged post-scabies itch that does not respond to the above, a clinician may consider gabapentin, doxepin, or — in refractory cases — narrowband UVB phototherapy.^[6]

When to Be Concerned: Distinguish Post-Treatment Itch from Reinfestation

Post-scabies pruritus and active reinfestation can feel identical. The key distinguishing findings are:

• New burrows appearing after treatment — a clear sign of active infestation
• New pimple-like nodules in classic scabies locations (between fingers, on wrists, genitals)
• Itch worsening past 4 weeks rather than gradually improving
• A household contact who was not treated and is now itching — the most common driver of genuine reinfestation

If any of these are present, re-evaluation — and likely retreatment along with simultaneous retreatment of all contacts — is appropriate. Do not retreat based on itch alone without clinical assessment; overtreatment with permethrin can itself cause skin irritation and worsening itch.

Scabies in Institutional Settings

Scabies outbreaks in nursing homes, long-term care facilities, hospitals, prisons, and childcare centers present a specific public health challenge that goes beyond treating individual patients. A single undiagnosed case — especially crusted scabies — can spread to dozens of residents and staff before the first case is identified.

Why Institutional Outbreaks Are Different

Several features make institutional management more complex than household treatment:

• Many residents may be immunocompromised, elderly, or cognitively impaired — limiting their ability to report symptoms or cooperate with full-body treatment application.
• The institutional environment (shared dining areas, common rooms, hands-on care) creates repeated exposure opportunities among staff, residents, and visitors.
• Crusted scabies may be present in one or more residents before classic scabies is recognized, seeding the outbreak with a disproportionately high-mite source.
• Staff who receive treatment can return to work the day after treatment with permethrin or ivermectin. Symptomatic staff who provide hands-on patient care should use disposable gloves for several days post-treatment until cure is confirmed.^[4]

Outbreak Response Framework

The CDC recommends the following approach for institutional outbreaks:^[4]

• Identify and treat all cases and contacts simultaneously. This includes all residents with any undiagnosed rash, all staff who had skin-to-skin contact with infested individuals, household members of treated staff, and visiting family members who had prolonged contact.
• Maintain active surveillance. Track new cases by name, room number, care staff, and contact history to map the outbreak and identify ongoing transmission chains.
• Implement infection control measures during treatment: gloves and gowns for hands-on care, avoidance of skin-to-skin contact, and isolation of confirmed crusted scabies cases.
• Environmental measures: Machine-wash and hot-dry all bedding and towels; seal non-launderable items; routine cleaning and vacuuming of patient rooms and common areas. Pesticide sprays are not needed or recommended.
• Maintain high suspicion for new and returning residents — screen new admissions and report multiple cases to the local health department.

Oral ivermectin is particularly practical in institutional settings because administering a single oral tablet is far easier to confirm and document than ensuring every resident receives a correct full-body permethrin application.

Telehealth and Scabies: What a Virtual Visit Can Do

In my clinical experience, scabies is well-suited to telehealth evaluation in most cases. The diagnosis rests heavily on history and pattern recognition: where is the rash, how long has it been present, does it affect others in the household, is the itch worse at night, and has anything improved it? These are all questions a clinician can ask and assess during a video visit.

Classic scabies presentations — burrows between the fingers, intense nocturnal itch, simultaneous symptoms in household members — allow for a confident clinical diagnosis without an in-person skin scraping. A prescriber can assess photographs of the rash, ask the right screening questions, and issue prescriptions for permethrin 5% cream or oral ivermectin, along with detailed written instructions for application and household decontamination.

Telehealth is particularly well-suited to scabies because:

• Patients are often embarrassed to seek in-person care due to the stigma around scabies — a virtual visit removes that barrier entirely.
• The prescriber can coordinate simultaneous treatment prescriptions for multiple household members in a single visit.
• Post-treatment follow-up (to distinguish normal post-treatment itch from reinfestation) is an ideal telehealth use case.
• Patients in underserved areas or with limited transportation can access care that would otherwise require a dermatology referral.

Managing Symptoms and Secondary Complications

Scabicide treatment addresses the infestation itself. Several additional interventions help manage the consequences of chronic scratching and the immune response:

• Antihistamines — oral antihistamines, especially sedating agents taken at bedtime, reduce itch intensity and improve sleep, which is significantly disrupted in most patients with active scabies.
• Topical corticosteroids — medium-potency topical steroids reduce inflammation and provide itch relief during and after treatment. They are appropriate for controlling post-treatment pruritus.
• Antibiotics for secondary infection — intense scratching can break the skin barrier, allowing Staphylococcus aureus and Streptococcus pyogenes to cause secondary impetigo or cellulitis. This occurs commonly in children and requires prompt antibiotic treatment. Signs include crusted, honey-colored plaques (impetigo) or spreading redness, warmth, and swelling (cellulitis).
• Moisturizers — fragrance-free emollients help restore the skin barrier disrupted by chronic inflammation and scratching, reducing irritant-driven itch independent of the mite response.
• Nail trimming before applying permethrin reduces the mite burden under the nails (a protected location) and reduces skin damage from scratching.